NCT05768958

Brief Summary

The overall aim is to investigate effects of acute exercise on ad libitum energy intake and study whether this differs between morning and evening in individuals with overweight/obesity with or without type 2 diabetes (T2D). Furthermore, the aim is to examine the role of hedonic and homeostatic drivers of appetite control in obesity and T2D in the context of meal and exercise timing.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
2mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress96%
Mar 2023Jul 2026

First Submitted

Initial submission to the registry

February 15, 2023

Completed
28 days until next milestone

First Posted

Study publicly available on registry

March 15, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

March 22, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2024

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

May 30, 2025

Status Verified

May 1, 2025

Enrollment Period

1.4 years

First QC Date

February 15, 2023

Last Update Submit

May 23, 2025

Conditions

Keywords

OverweightObesityTimingAcute exerciseCircadian rythmAppetiteType 2 diabetesMetabolism

Outcome Measures

Primary Outcomes (1)

  • Ad libitum energy intake (KJ) after exercise compared with rest

    Food intake (KJ) is measured after meal completion, exercise compared with rest

    Measured after meal consumption at t = 30 minutes

Secondary Outcomes (37)

  • Ad libitum energy intake (KJ) after exercise in the morning compared with evening

    Measured after meal consumption at t = 30 minutes

  • Ad libitum energy intake (KJ) after rest in the morning compared with evening

    Measured after meal consumption at t = 30 minutes

  • Eating pace (KJ/min)

    Measured from start to finish of meal consumption at t = 15 minutes to end of meal, morning and evening, exercise and rest

  • Glucose (mmol/L)

    Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest

  • Triglyceride (mmol/L)

    Fasting (t = -60 minutes) and at t = 0, 15, 30, 45, 60 minutes, morning and evening, exercise and rest

  • +32 more secondary outcomes

Study Arms (4)

Morning exercise

EXPERIMENTAL

Study visit performed in the morning with 45 min exercise.

Other: Exercise

Morning control

EXPERIMENTAL

Study visit performed in the morning with 45 min rest period.

Other: Control

Evening exercise

EXPERIMENTAL

Study visit performed in the evening with 45 min exercise.

Other: Exercise

Evening control

EXPERIMENTAL

Study visit performed in the evening with 45 min rest period.

Other: Control

Interventions

45 min exercise bout performed on bicycle ergometer. The exercise bout will consist of a 10 min warm-up period at 40 % Watt max followed by 4 cycles of 4 min at 85 % Watt max and 3 min at 50 % Watt max. A cool-down period (7 min) will be performed at 40 % Watt max.

Evening exerciseMorning exercise
ControlOTHER

45 min rest during the same time period as the exercise bout on exercise study visits.

Evening controlMorning control

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults with overweight or obesity (BMI \>25 kg/m2) with and without T2D
  • HbA1c ≥48 mmol/mol for people with T2D

You may not qualify if:

  • Not able to eat ad libitum meal
  • Not able to perform the exercise bout
  • Daily smoking
  • For women: Pregnancy / planned pregnancy (within the study period) / lactating
  • Self-reported history of an eating disorder in the past 3 years
  • Treatment with antidepressants
  • Treatment with fast acting insulin, combination insulin products and sulfonylureas
  • Uncontrolled medical issues including but not limited to cardiovascular pulmonary, rheumatologic, hematologic, oncologic, infectious, gastrointestinal, or psychiatric disease; diabetes or other endocrine disease; immunosuppression
  • Current treatment with medication which significantly affect appetite or energy balance (e.g., GLP-1 receptor agonists)
  • Bariatric surgery
  • Unable to understand the informed consent and the study procedures
  • Concomitant participation in intervention studies
  • Incapable of understanding Danish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Steno Diabetes Center Copenhagen

Herlev, DK-2730, Denmark

Location

Related Publications (1)

  • Jalking L, Launbo NP, Jensen MM, Pedersen HE, Blond MB, Gerstenberg MK, Finlayson G, Beaulieu K, Faerch K, Grunnet LG, Quist JS. Effects of exercise and exercise timing on energy intake and appetite control in Danish individuals with overweight or obesity with and without type 2 diabetes: a protocol for a randomised controlled cross-over trial. BMJ Open. 2025 Feb 6;15(2):e092683. doi: 10.1136/bmjopen-2024-092683.

MeSH Terms

Conditions

OverweightObesityDiabetes Mellitus, Type 2

Interventions

Exercise

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Kristine Færch, PhD

    Steno Diabetes Center Copenhagen

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 15, 2023

First Posted

March 15, 2023

Study Start

March 22, 2023

Primary Completion

August 21, 2024

Study Completion (Estimated)

July 31, 2026

Last Updated

May 30, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share

Data from the trial will not be made publicly available as individual data from participants are protected by EU's GDPR (General Data Protection Regulation) laws and Danish Data Protection laws. Study results can be made available upon reasonable request from the corresponding author.

Shared Documents
STUDY PROTOCOL, ICF

Locations